rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2006-12-20
|
pubmed:abstractText |
Roflumilast is an oral, once-daily phosphodiesterase 4 inhibitor under investigation for the treatment of chronic obstructive pulmonary disease and asthma. In clinical practice, the drug is likely to be co-administered with inhaled bronchodilating beta2-adrenoceptor agonists. Therefore, this study investigated the pharmacokinetic characteristics of roflumilast and its pharmacodynamically active metabolite roflumilast N-oxide when co-administered with orally inhaled salbutamol in healthy subjects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0946-1965
|
pubmed:author |
pubmed-author:BethkeT DTD,
pubmed-author:DavidMM,
pubmed-author:GiessmannTT,
pubmed-author:HaunsBB,
pubmed-author:HauschkeDD,
pubmed-author:HermannRR,
pubmed-author:LaibKK,
pubmed-author:SiegmundWW,
pubmed-author:WeinbrennerAA,
pubmed-author:WestphalKK,
pubmed-author:ZechKK
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
572-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17176624-Adrenergic beta-Agonists,
pubmed-meshheading:17176624-Adult,
pubmed-meshheading:17176624-Albuterol,
pubmed-meshheading:17176624-Aminopyridines,
pubmed-meshheading:17176624-Benzamides,
pubmed-meshheading:17176624-Bronchodilator Agents,
pubmed-meshheading:17176624-Cyclopropanes,
pubmed-meshheading:17176624-Drug Interactions,
pubmed-meshheading:17176624-Humans,
pubmed-meshheading:17176624-Male,
pubmed-meshheading:17176624-Phosphodiesterase Inhibitors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.
|
pubmed:affiliation |
ALTANA Pharma AG, Konstanz, Germany.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|